Inogen appoints Vafa Jamali to board, enters cooperation agreement with Kent Lake

Inogen Inc

Vafa Jamali appointed as independent Class I director effective June 15, 2026 or 2026 annual meeting.
Jamali previously CEO of ZimVie and SVP/President of Medtronic's $3B Respiratory, GI & Informatics division.
Cooperation agreement with Kent Lake includes standstill, voting commitment, and 4.99% ownership cap.
Jamali to receive $180k initial RSU grant, plus annual cash fees of $60k for board and committee roles.
Kent Lake agreed to vote shares per board recommendations except on extraordinary transactions.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Inogen Inc entered into Cooperation Agreement with Kent Lake Partners LP, Kent Lake PR LLC and Benjamin Natter (effective 2026-04-06).

Action: entry
Counterparty: Kent Lake Partners LP, Kent Lake PR LLC and Benjamin Natter
Effective: 2026-04-06

Exact text from the filing

On April 6, 2026, the Company entered into a Cooperation Agreement (the “Cooperation Agreement”) with Kent Lake Partners LP (“Kent Lake”), Kent Lake PR LLC (“Kent Lake PR”) and Benjamin Natter

View on SEC.gov

825 material agreements filed in the last 30 days. Browse all material agreements →

Inogen Inc filing history →

Source: SEC EDGAR

accession 0001193125-26-143703

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.